ClinicalTrials.Veeva

Menu

Flare Measurements in Human Radiation Therapy Patients

C

ChromoLogic

Status

Completed

Conditions

The Impact of Whole Body Irradiation on Ocular Flare

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01640236
OCDOS_PRO_110314_02

Details and patient eligibility

About

This is a longitudinal Feasibility Study of a novel non-invasive device in assessing radiation dose exposure in humans. All patients receiving whole body irradiation therapy and meeting all other inclusion/exclusion criteria will receive ocular flare meter measurements and slit-lamp examinations on up to eleven occasions starting prior to the first fractional dose of irradiation.

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects must be scheduled to receive whole body irradiation in a dose range from 1.5 to 12Gy.
  • Subjects must not have received ocular surgery for at least three months prior to study enrolment.
  • Subjects must not have a history of uveitis.
  • Subjects must have at least one eye free of cataracts
  • Subject age must be greater than 18 years
  • Subjects must have the ability to understand and willingness to sign a written informed consent document.

Exclusion criteria

  • Inability to give informed consent
  • Cataracts in both eyes
  • Subject has received ocular surgery within the prior three months
  • Subject has a history of uveitis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems